Has Thomas Tsao received payments from drug or device companies?

Yes. Drug and device makers reported $2,982 in general payments to Thomas Tsao across 191 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Tsao did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Tsao come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Tsao

Child & Adolescent Psychiatry · Virginia Beach, VANPI 1659343556

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations.

$2,982in general payments, 2019–2025

Across 191 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lundbeck LLC$457
Otsuka America Pharmaceutical, Inc.$438
Takeda Pharmaceuticals U.S.A., Inc.$411
Sunovion Pharmaceuticals Inc.$343
Johnson & Johnson$256
Supernus Pharmaceuticals, Inc.$190
plus $887 from 18 others

What the payments were for

Food & beverage$2,982100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lundbeck LLC	30	$457
Otsuka America Pharmaceutical, Inc.	30	$438
Takeda Pharmaceuticals U.S.A., Inc.	26	$411
Sunovion Pharmaceuticals Inc.	28	$343
Johnson & Johnson	12	$256
Supernus Pharmaceuticals, Inc.	14	$190
Novartis	6	$104
AbbVie	3	$97
Neurocrine Biosciences, Inc.	6	$96
Corium, LLC	5	$89
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$76
Shire North American Group Inc	4	$68
Tris Pharma Inc	3	$57
Ironshore Pharmaceuticals Inc.	4	$51
Almatica Pharma LLC	3	$44
Neos Therapeutics, LP	2	$34
Jazz Pharmaceuticals Inc.	2	$33
Vanda Pharmaceuticals Inc.	2	$27
Adlon Therapeutics L.p.	2	$25
Alkermes, Inc.	1	$25
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$18
Eisai Inc.	1	$15
UCB, Inc.	1	$14
Livanova USA, Inc.	1	$12

How this compares

$2,982 in reported general payments places this provider in the 85th percentile of 115 child & adolescent psychiatry providers in Virginia.

See all child & adolescent psychiatry providers in Virginia →

Other child & adolescent psychiatry in Virginia Beach

Frank RobertoVirginia Beach$808
John RiedlerVirginia Beach$729
Christina UnderwoodVirginia Beach$453
Matthew SachsVirginia Beach$384
Charles HallRichmond$10K
Chandramouleswar AmaraPetersburg$10K
David GouldRichmond$9K
Rakesh ShahHopewell$7K
Vikas MangewalaFairfax$7K
Maria Carmen Rita Gonzales VigilarAshburn$6K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →